← Back to Clinical Trials
Recruiting NCT06822647

NCT06822647 Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06822647
Status Recruiting
Phase
Sponsor Henry Ford Health System
Condition Cervical Insufficiency
Study Type INTERVENTIONAL
Enrollment 550 participants
Start Date 2025-01-20
Primary Completion 2027-06-01

Trial Parameters

Condition Cervical Insufficiency
Sponsor Henry Ford Health System
Study Type INTERVENTIONAL
Phase N/A
Enrollment 550
Sex FEMALE
Min Age N/A
Max Age N/A
Start Date 2025-01-20
Completion 2027-06-01
Interventions
Cervical Length Measurement at the Beginning of the Anatomy SurveyCervical Length Measurement at the End of the Anatomy Survey

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to determine the optimal timing for measuring cervical length (CL) during fetal anatomy surveys in pregnant individuals. This study focuses on improving the accuracy of cervical length assessments, which are critical for identifying individuals at risk for preterm birth. The main questions it aims to answer are: * Does measuring cervical length at the beginning of the anatomy survey result in a higher proportion of scans meeting the nine CLEAR (Cervical Length Education and Review) criteria compared to measuring at the end of the survey? * Does the use of sepia-filtered ultrasound images improve the proportion of scans meeting the nine CLEAR criteria compared to conventional grayscale images? Researchers will compare two groups of participants randomized to have cervical length measured either at the beginning or at the end of the anatomy survey. Additionally, all participants will undergo cervical length measurements using both grayscale and sepia-filtered ultrasound imaging. Participants will: * Receive a patient information sheet through MyChart explaining the study and standard cervical length screening during anatomy surveys. * Provide verbal consent for a transvaginal ultrasound and study participation. * Be randomized to have their cervical length measured at either the start or end of the fetal survey. * Undergo cervical length measurement using both grayscale and sepia-filtered ultrasound imaging modalities. * This study involves no additional risks beyond those of routine clinical care and aims to enhance clinical practice by identifying optimal methods for cervical length assessment during pregnancy.

Eligibility Criteria

Inclusion Criteria: * Pregnant individuals between 16 weeks and 23 weeks + 6 days of gestation. * Presenting for a fetal anatomy survey at Henry Ford Health MFM ultrasound units. * Consent to a transvaginal cervical length measurement as part of routine care. * Agreement to participate in the study, including randomization for the timing of cervical length measurement. Exclusion Criteria: * History of preterm delivery. * Diagnosis of cervical insufficiency. * Declines or unable to consent to a transvaginal cervical length measurement. * Patients receiving care at non-Henry Ford Health radiology clinics.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology